| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
|
J Natl Cancer Inst
|
2006
|
6.02
|
|
2
|
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.
|
J Clin Oncol
|
2011
|
5.27
|
|
3
|
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
|
J Natl Cancer Inst
|
2007
|
4.85
|
|
4
|
Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
|
J Natl Cancer Inst
|
2007
|
4.24
|
|
5
|
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.
|
Urology
|
2007
|
4.02
|
|
6
|
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
|
J Urol
|
2011
|
3.36
|
|
7
|
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12.
|
Nat Genet
|
2008
|
3.14
|
|
8
|
Delayed versus immediate surgical intervention and prostate cancer outcome.
|
J Natl Cancer Inst
|
2006
|
2.96
|
|
9
|
Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.
|
Eur Urol
|
2012
|
2.92
|
|
10
|
The effect of shock wave rate on the outcome of shock wave lithotripsy: a meta-analysis.
|
J Urol
|
2007
|
2.78
|
|
11
|
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.
|
BJU Int
|
2012
|
2.77
|
|
12
|
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up.
|
BJU Int
|
2011
|
2.68
|
|
13
|
Retracted
EPCA-2: a highly specific serum marker for prostate cancer.
|
Urology
|
2007
|
2.67
|
|
14
|
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillance.
|
J Urol
|
2013
|
2.66
|
|
15
|
Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
|
Urology
|
2013
|
2.42
|
|
16
|
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment.
|
J Clin Invest
|
2005
|
2.38
|
|
17
|
Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.
|
Am J Surg Pathol
|
2011
|
2.20
|
|
18
|
Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomy.
|
Urology
|
2013
|
2.11
|
|
19
|
National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults.
|
Ann Intern Med
|
2008
|
2.10
|
|
20
|
Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer.
|
J Urol
|
2004
|
1.85
|
|
21
|
Gleason score 6 adenocarcinoma: should it be labeled as cancer?
|
J Clin Oncol
|
2012
|
1.78
|
|
22
|
Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation.
|
Urology
|
2009
|
1.74
|
|
23
|
Association of prostate cancer risk variants with clinicopathologic characteristics of the disease.
|
Clin Cancer Res
|
2008
|
1.74
|
|
24
|
Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols.
|
BJU Int
|
2014
|
1.73
|
|
25
|
Validity of administrative coding in identifying patients with upper urinary tract calculi.
|
J Urol
|
2010
|
1.72
|
|
26
|
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
|
J Clin Oncol
|
2005
|
1.69
|
|
27
|
Laparoscopic live donor nephrectomy: trends in donor and recipient morbidity following 381 consecutive cases.
|
Ann Surg
|
2004
|
1.63
|
|
28
|
Prostate specific antigen testing among the elderly--when to stop?
|
J Urol
|
2009
|
1.62
|
|
29
|
Causes of death after radical prostatectomy at a large tertiary center.
|
J Urol
|
2012
|
1.61
|
|
30
|
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
|
Prostate
|
2008
|
1.53
|
|
31
|
Radical retropubic prostatectomy. How often do experienced surgeons have positive surgical margins when there is extraprostatic extension in the region of the neurovascular bundle?
|
J Urol
|
2005
|
1.52
|
|
32
|
Medical comorbidities associated with pediatric kidney stone disease.
|
Urology
|
2010
|
1.50
|
|
33
|
What are the outcomes of radical prostatectomy for high-risk prostate cancer?
|
Urology
|
2009
|
1.49
|
|
34
|
Risk stratification of men choosing surveillance for low risk prostate cancer.
|
J Urol
|
2010
|
1.47
|
|
35
|
Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience.
|
Prostate
|
2013
|
1.46
|
|
36
|
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.
|
BJU Int
|
2012
|
1.44
|
|
37
|
Laparoscopic partial nephrectomy: effect of warm ischemia on serum creatinine.
|
J Urol
|
2004
|
1.44
|
|
38
|
Modeling grade progression in an active surveillance study.
|
Stat Med
|
2013
|
1.41
|
|
39
|
Treatment decision-making for localized prostate cancer: what younger men choose and why.
|
Prostate
|
2011
|
1.30
|
|
40
|
Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy.
|
Urology
|
2008
|
1.27
|
|
41
|
Prostate cancer mortality following active surveillance versus immediate radical prostatectomy.
|
Clin Cancer Res
|
2012
|
1.25
|
|
42
|
Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.
|
J Urol
|
2004
|
1.24
|
|
43
|
The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary.
|
J Urol
|
2012
|
1.24
|
|
44
|
Impact of renal artery multiplicity on outcomes of renal donors and recipients in laparoscopic donor nephrectomy.
|
Urology
|
2003
|
1.15
|
|
45
|
Impact of surgical margin status on prostate-cancer-specific mortality.
|
BJU Int
|
2012
|
1.13
|
|
46
|
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy.
|
J Urol
|
2007
|
1.10
|
|
47
|
Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
|
BJU Int
|
2013
|
1.06
|
|
48
|
Impact of patient age on biochemical recurrence rates following radical prostatectomy.
|
J Urol
|
2007
|
1.06
|
|
49
|
Acceptability of diagnostic tests for breast cancer.
|
Breast Cancer Res Treat
|
2003
|
1.05
|
|
50
|
Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy.
|
J Urol
|
2005
|
1.05
|
|
51
|
The safety of ureteroscopy during pregnancy: a systematic review and meta-analysis.
|
J Urol
|
2008
|
1.02
|
|
52
|
Allogeneic versus autologous blood transfusion and survival after radical prostatectomy.
|
Transfusion
|
2014
|
1.00
|
|
53
|
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
|
J Urol
|
2007
|
0.98
|
|
54
|
Salvage or adjuvant radiation therapy: counseling patients on the benefits.
|
J Natl Compr Canc Netw
|
2010
|
0.97
|
|
55
|
A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria.
|
J Urol
|
2002
|
0.93
|
|
56
|
Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching.
|
Urology
|
2008
|
0.92
|
|
57
|
Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate.
|
Urology
|
2006
|
0.92
|
|
58
|
Incidence and risk factors for inguinal and incisional hernia after laparoscopic radical prostatectomy.
|
Urology
|
2011
|
0.92
|
|
59
|
In vitro fertilization and the cloacal-bladder exstrophy-epispadias complex: is there an association?
|
J Urol
|
2003
|
0.92
|
|
60
|
3-year actuarial biochemical recurrence-free survival following laparoscopic radical prostatectomy: experience from a tertiary referral center in the United States.
|
J Urol
|
2008
|
0.91
|
|
61
|
Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction.
|
J Urol
|
2008
|
0.90
|
|
62
|
Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network.
|
Prostate
|
2013
|
0.89
|
|
63
|
Active surveillance for low-risk prostate cancer.
|
Crit Rev Oncol Hematol
|
2012
|
0.89
|
|
64
|
Is pelvic osteotomy associated with lower risk of pelvic organ prolapse in postpubertal females with classic bladder exstrophy?
|
J Urol
|
2012
|
0.89
|
|
65
|
The effect of ureteral stent placement on post-ureteroscopy complications: a meta-analysis.
|
Urology
|
2008
|
0.88
|
|
66
|
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
|
J Urol
|
2009
|
0.88
|
|
67
|
Complications of renal cryoablation: a single center experience.
|
J Urol
|
2010
|
0.85
|
|
68
|
Prognostic significance of preoperative molecular serum analysis in renal cancer.
|
Clin Cancer Res
|
2002
|
0.84
|
|
69
|
Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy.
|
J Urol
|
2008
|
0.84
|
|
70
|
Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.
|
BJU Int
|
2010
|
0.83
|
|
71
|
Laparoscopic and robotic radical prostatectomy outcomes in obese and extremely obese men.
|
Urology
|
2013
|
0.82
|
|
72
|
Epidemiologic insights into pediatric kidney stone disease.
|
Urol Res
|
2010
|
0.82
|
|
73
|
Effect of failed initial closure on bladder growth in children with bladder exstrophy.
|
J Urol
|
2011
|
0.82
|
|
74
|
Differential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cells.
|
J Biomed Biotechnol
|
2008
|
0.82
|
|
75
|
Aquaporin-1 promoter hypermethylation is associated with improved prognosis in salivary gland adenoid cystic carcinoma.
|
Otolaryngol Head Neck Surg
|
2014
|
0.81
|
|
76
|
Can we stop prostate specific antigen testing 10 years after radical prostatectomy?
|
J Urol
|
2011
|
0.81
|
|
77
|
Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.
|
Urology
|
2007
|
0.80
|
|
78
|
Clinical efficacy of sildenafil citrate and predictors of long-term response.
|
J Urol
|
2003
|
0.79
|
|
79
|
Comparison of open and laparoscopic radical prostatectomy outcomes from a surgeon's early experience.
|
Urology
|
2007
|
0.78
|
|
80
|
Elective laparoscopic partial nephrectomy in patients with tumors >4 cm.
|
Urology
|
2008
|
0.78
|
|
81
|
Re: randomised prostate cancer screening trial: 20 year follow-up.
|
Eur Urol
|
2011
|
0.77
|
|
82
|
The impact of preoperative erectile dysfunction on survival after radical prostatectomy.
|
BJU Int
|
2010
|
0.76
|
|
83
|
Re: Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease: N. D. Arvold, M. H. Chen, J. W. Moul, B. J. Moran, D. E. Dosoretz, L. L. Bañez, M. J. Katin, M. H. Braccioforte and A. V. D'Amico J Urol 2011; 186: 91-96.
|
J Urol
|
2011
|
0.75
|
|
84
|
Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death.
|
Cancer
|
2010
|
0.75
|
|
85
|
Re: Radiation therapy after radical prostatectomy: impact on metastasis and survival S. A. Boorjian, R. J. Karnes, P. L. Crispen, L. J. Rangel, E. J. Bergstralh and M. L. Blute J Urol 2009; 182: 2708-2715.
|
J Urol
|
2010
|
0.75
|
|
86
|
Laparoscopic adult donor nephrectomy for pediatric renal transplantation.
|
Urology
|
2003
|
0.75
|
|
87
|
Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry.
|
J Urol
|
2017
|
0.75
|